May 12 (SeeNews) - Pharmaceutical giant GlaxoSmithKline (GSK) will invest 10 million euro ($13.7 million) to launch the production of a new antidepressant drug in its factory in the central Romanian city of Brasov, Bucharest-based daily Business Standard reported on Tuesday.